📕 SEPTEMBER ISSUE. With Review articles on deep brain stimulation in alpha-synuclein models of Parkinson's disease and the structural biology of alpha-synuclein amyloid filaments.

🔗 Explore: journals.sagepub.com/toc/pkna/16/6

#ParkinsonsDisease #ParkinsonsResearch #DeepBrainStimulation

How can we create a more equitable future for Parkinson's care?

Explore advocacy, policy, and health disparities in this special issue.

Read more: ow.ly/XBYk50ZWqRq #ParkinsonsDisease #GlobalHealth #HealthEquity @journal_PD

📰 High engagement #review article in #JPD

Defining Parkinson’s Disease: Past and Future, by Kulcsarova et al.

🔗 Read here: doi.org/10.3233/JPD-23…

#Parkinsons #ParkinsonsDisease #ParkinsonsResearch #Genetics

Trending in JPD: @FHU_PR study finds that a stool test measuring a mucin-degrading Akkermansia nanA gene may help indicate the presence and severity of Parkinson's disease.

🔗 Read here: journals.sagepub.com/doi/10.1177/18…

#Parkinsons #ParkinsonsResearch #PDResearch

Helicobacter pylori (H pylori) infection and gastritis are associated with a modestly increased risk for developing Parkinson disease, according to findings published in JPD.

🔗 Read more: neurologyadvisor.com/news/h-pylori-…

#Parkinsons #ParkinsonsDisease #HPylori #Gastritis

What is the relationship between Parkinson’s and dementia? In our webinar on Wednesday 9 September at 5pm BST, Edinburgh University’s Professor Tilo Kunath and an expert panel will discuss dementia, Parkinson's and the current research landscape. Register: buff.ly/a1rKqKH

Webinar: Parkinson's and Dementia, 9 September 2026, 5-6pm BST, 12-1pm ET.

Professor Tilo Kunath and an expert panel will discuss types of dementia closely associated with Parkinson's, how they compare, and the current research landscape.

🔗 Register: eventbrite.co.uk/e/webinar-park…

Explore Review articles from #WPC2026 in @journal_PD
#Parkinsons #ParkinsonsResearch

View the collection:
journals.sagepub.com/topic/collecti…

Nominations for our annual Tom Isaacs Award are open! 🏆

The Tom Isaacs Award recognises a researcher who is making a meaningful difference to people affected by Parkinson’s by working with them, not just for them.

Nominations close Sunday 2 August: buff.ly/asjUUfe

Nominations for Cure Parkinson’s annual Tom Isaacs Award extended till 9 August 🏆 This award recognises a researcher who is making a meaningful difference to people affected by Parkinson’s by working with them, not just for them. Nominate a researcher at cureparkinsons.org.uk/research/get-i…

⌛️ Published in JPD, the most in-depth analysis ever undertaken of Parkinson’s drug clinical trials has discovered that research largely aimed at slowing or stopping the condition has overtaken that of symptom management.

Read more: healthcaretoday.com/article/parkin…

Read the study in JPD: journals.sagepub.com/doi/10.1177/18…

Parkinson’s disease is not contagious, but its rapidly rising worldwide burden has led experts to use the term Parkinson pandemic to emphasize the urgent need for coordinated global action. Shalash and colleagues describe in a new paper in the Journal of Parkinson's Disease how ’s disease is accelerating worldwide and what can be done to change its trajectory.
Key points:
- Parkinson’s disease is now the fastest growing neurological disorder worldwide, driven by population aging, longer life expectancy, environmental exposures, and improved recognition of the disease.
- The burden of Parkinson’s disease differs dramatically across regions because of differences in genetics, pesticides, air pollution, industrial chemicals, health care access, and socioeconomic factors.
- The authors propose a global roadmap that includes reducing environmental toxicants, improving access to levodopa and expert care, expanding research, supporting caregivers, and strengthening public awareness.
My take: This review reinforces what many of us have been saying for years. Parkinson's disease is not simply an inevitable consequence of aging. The growing global burden reflects a complex interaction of aging, environmental exposures, genetics, and disparities in health care. The encouraging news is that many of these factors are potentially modifiable. We should not simply count cases of Parkinson's disease. We should work together to prevent them.
Here are 5 points that resonated w/ me:
1- Aging explains much of the increase in Parkinson's disease, however it does not explain it all. Environmental exposures remain an important piece of the puzzle.
2- Universal access to levodopa and multidisciplinary Parkinson's care should be viewed as a global public health priority, not a luxury.
3- Preventing exposure to neurotoxic pesticides, industrial solvents, and air pollution may reduce future Parkinson's disease burden if coupled w/ stronger public health policies.
4- Supporting caregivers, educating health care providers, and improving early diagnosis are just as important as discovering new treatments.
5- The future will depend on global collaboration that brings together researchers, governments, advocacy organizations, industry, and folks living w/ Parkinson's disease to slow this pandemic before it grows even larger.
journals.sagepub.com/doi/10.1177/18…

📕 AUGUST ISSUE. With Review articles on gastroparesis in Parkinson's disease (PD) and advances in sex-specific single-cell transcriptomic profiling in PD.

🔗 Explore the issue: journals.sagepub.com/toc/pkna/16/5

#ParkinsonsDisease #ParkinsonsResearch #ParkinsonsAwareness #Parkinsons

Missed the science at #WPC2026? The WPC 2026 Abstract Issue of @Journal_PD features the groundbreaking research presented at the 7th World Parkinson Congress by experts and advocates from around the world.
journals.sagepub.com/toc/pkna/16/1_…?
#Parkinsons #WPC2026

Missed the webinar on 'Mastering the Neurology Publication Journey'? Not to worry!

Catch up on the full webinar recording plus all relevant links and discussion points in the Sage Perspectives 'Webinar follow-up' blog post:

sagepub.com/explore-our-co… via @Sage_Publishing

💊 New Free-to-Read Special Issue: Roads towards a faster development of new pharmacotherapies for Parkinson's disease

🆓🔗 Read free here: journals.sagepub.com/toc/pkna/16/2_…

#parkinsonsdisease #parkinsonsawareness #Parkinsons #DrugTrials

📕 NEW ISSUE. Featuring Review articles on the Global Parkinson's Genetics Program and clinical GDNF delivery methods for Parkinson's disease.

Explore the issue: journals.sagepub.com/toc/pkna/16/4

#parkinsonsdisease #parkinsonsresearch #parkinsons #genetics

🎉 JPD has achieved its highest-ever Impact Factor of 𝟱.𝟵 📈

A huge thank you to our community, Co-Editors-in-Chief Bas Bloem (@basbloem) and Lorraine Kalia for their leadership, and to our publisher Sage.

#ParkinsonsResearch #ParkinsonsDisease #Parkinsons #ImpactFactor

📊 New in JPD: A 10-year analysis identified 444 Parkinson's drug trials aimed at targeting symptoms or slowing disease progression. Of these, 14 drugs have been approved to treat symptoms.

Read more: journals.sagepub.com/doi/full/10.11…

#ParkinsonsDisease #Parkinsons #parkinsonsresearch